- Home
- LGMK vs ATNF Comparison
LGMK vs ATNF Comparison
Compare LGMK & ATNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGMK
- ATNF
- Stock Information
- Founded
- LGMK 2011
- ATNF 2016
- Country
- LGMK United States
- ATNF United States
- Employees
- LGMK N/A
- ATNF N/A
- Industry
- LGMK Industrial Specialties
- ATNF Biotechnology: Pharmaceutical Preparations
- Sector
- LGMK Health Care
- ATNF Health Care
- Exchange
- LGMK Nasdaq
- ATNF Nasdaq
- Market Cap
- LGMK 3.6M
- ATNF 4.1M
- IPO Year
- LGMK N/A
- ATNF N/A
- Fundamental
- Price
- LGMK $0.26
- ATNF $1.25
- Analyst Decision
- LGMK
- ATNF
- Analyst Count
- LGMK 0
- ATNF 0
- Target Price
- LGMK N/A
- ATNF N/A
- AVG Volume (30 Days)
- LGMK 1.6M
- ATNF 84.0K
- Earning Date
- LGMK 03-26-2025
- ATNF 03-04-2025
- Dividend Yield
- LGMK N/A
- ATNF N/A
- EPS Growth
- LGMK N/A
- ATNF N/A
- EPS
- LGMK N/A
- ATNF N/A
- Revenue
- LGMK $10,078,502.00
- ATNF N/A
- Revenue This Year
- LGMK $1.54
- ATNF N/A
- Revenue Next Year
- LGMK N/A
- ATNF $54.15
- P/E Ratio
- LGMK N/A
- ATNF N/A
- Revenue Growth
- LGMK 4.44
- ATNF N/A
- 52 Week Low
- LGMK $0.25
- ATNF $1.16
- 52 Week High
- LGMK $32.25
- ATNF $17.75
- Technical
- Relative Strength Index (RSI)
- LGMK 11.06
- ATNF 33.17
- Support Level
- LGMK $0.25
- ATNF $1.31
- Resistance Level
- LGMK $0.73
- ATNF $1.38
- Average True Range (ATR)
- LGMK 0.08
- ATNF 0.06
- MACD
- LGMK -0.05
- ATNF 0.01
- Stochastic Oscillator
- LGMK 0.77
- ATNF 0.00
About LGMK LogicMark Inc. (NV)
LogicMark Inc provides personal emergency response systems (PERS), health communications devices, and IoT technologies to create a connected care platform. Its devices give people the ability to receive care at home and confidence to age in place. The company incorporates two-way voice communication technology directly into its medical alert pendant and provides this life-saving technology at a price point that everyday consumers can afford.
About ATNF 180 Life Sciences Corp.
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.